Eloxx Pharmaceuticals (ELOX) vs eXoZymes (EXOZ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Eloxx Pharmaceuticals is the larger company by market cap ($59.4 million vs $51.2 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELOX | EXOZ |
|---|---|---|
| Share price | $14.71 | $5.50 |
| Market cap | $59.36M | $51.18M |
| 1-day change | -1.18% | -0.72% |
| YTD return | — | -49.17% |
| 1-year return | — | -58.96% |
| P/E ratio (TTM) | 4.18 | — |
| EPS (TTM) | $3.52 | $-1.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $23.40 | $18.40 |
| 52-week low | $8.20 | $4.35 |
| Distance from 52-week high | -37.16% | -70.11% |
| Average volume | 46.44K | 6.80K |
| Shares outstanding | 4.04M | 9.30M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ELOX vs EXOZ FAQ
Which is bigger, Eloxx Pharmaceuticals or eXoZymes?
Eloxx Pharmaceuticals (ELOX) is larger, with a market capitalization of $59.36M compared with $51.18M for eXoZymes (EXOZ).
Are Eloxx Pharmaceuticals and eXoZymes in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.